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Abstract
Background: Iron deficiency without overt anemia is a known problem in athletic and physically active
women. The exact prevalence in this population in unclear but appears to range from 25-58%. The reasons for
this phenomenon are multifactorial and include iron losses, decreased iron absorption and lack of iron
consumption in the diet. Iron plays many roles in the human body that can affect exercise performance. Irons
main function is to carry and store oxygen throughout the body as a component of hemoglobin and
myoglobin. Iron is also a component of cytochromes, in coenzymes in the Krebs cycle and part of the electron
transport chain all of which are necessary for endurance activity. The purpose of this review is to evaluate the
effects of iron repletion on endurance performance in female athletes who are iron deficient but not anemic.
Methods: An extensive literature search of the following databases, MEDLINE-PubMed, MEDLINE-Ovid,
Web of Science, and CINAHL for the terms “sports,” “dietary supplements,” and “iron” was performed.
Results were further limited to articles in the English language and studies performed on human subjects.
Further inclusion criteria included active females greater than 17 years of age, premenopausal, iron deficient,
oral iron supplementation and studies where exercise performance was evaluated. Exclusion criteria included
anemic subjects, parenteral iron supplementation and treatment less than four weeks. All included studies
were double blinded and placebo controlled without crossover. The quality of the relevant studies was
evaluated using the GRADE criteria .
Results: Two studies met the inclusion criteria and were reviewed. Both studies showed that iron
replacement therapy increases iron stores but neither found an improvement in endurance capacity.
Conclusion: Although iron deficiency is a common problem in female athletes and active women, current
studies do not show that there is a performance benefit with iron supplementation in women who are not
anemic. However, this question is far from answered. Studies employing a more homogenous group of
athletes performing a prescribed training program for a period longer than eight weeks are necessary to fully
understand the impact of iron supplementation on athletes.
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Abstract   
 
Background: Iron deficiency without overt anemia is a known problem in athletic and 
physically active women. The exact prevalence in this population in unclear but appears 
to range from 25-58%. The reasons for this phenomenon are multifactorial and include 
iron losses, decreased iron absorption and lack of iron consumption in the diet. Iron plays 
many roles in the human body that can affect exercise performance. Irons main function 
is to carry and store oxygen throughout the body as a component of hemoglobin and 
myoglobin. Iron is also a component of cytochromes, in coenzymes in the Krebs cycle 
and part of the electron transport chain all of which are necessary for endurance activity. 
The purpose of this review is to evaluate the effects of iron repletion on endurance 
performance in female athletes who are iron deficient but not anemic. 
Methods:  An extensive literature search of the following databases, MEDLINE-
PubMed, MEDLINE-Ovid, Web of Science, and CINAHL for the terms “sports,” 
“dietary supplements,” and “iron” was performed. Results were further limited to articles 
in the English language and studies performed on human subjects. Further inclusion 
criteria included active females greater than 17 years of age, premenopausal, iron 
deficient, oral iron supplementation and studies where exercise performance was 
evaluated. Exclusion criteria included anemic subjects, parenteral iron supplementation 
and treatment less than four weeks.  All included studies were double blinded and 
placebo controlled without crossover. The quality of the relevant studies was evaluated 
using the GRADE criteria. 
Results:  Two studies met the inclusion criteria and were reviewed. Both studies showed 
that iron replacement therapy increases iron stores but neither found an improvement in 
endurance capacity.  
Conclusion: Although iron deficiency is a common problem in female athletes and active 
women, current studies do not show that there is a performance benefit with iron 
supplementation in women who are not anemic. However, this question is far from 
answered. Studies employing a more homogenous group of athletes performing a 
prescribed training program for a period longer than eight weeks are necessary to fully 
understand the impact of iron supplementation on athletes. 
Keywords:  iron, sports, dietary supplementation 
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Impact of Oral Iron Therapy on Exercise 
Performance in Iron Deficient Adult Female 
Athletes 
BACKGROUND 
 Iron deficiency without overt anemia is a recognized problem in physically active 
women and female athletes. The exact prevalence is unclear but appears to range from 
25-58% in the active population and affects upwards of 70% of athletes during the 
competitive season.
1-3
 The reasons for this phenomenon are multifactorial, with iron loss 
during menses, which can reach 0.6mg/d,
2, 4-8
 and inadequate dietary intake being the 
predominate factors. Other factors include: the use of NSAIDs, prior history of 
deficiency, recent blood loss, heavy menses, and history of untreated H. pylori infection.
4, 
7
 Combined with the basal iron needs of the body these factors lead to the recommended 
dietary allowance (RDA) for iron to be 18mg/d in premenopausal women. Despite this 
recommendation, data suggest that most women consume only 12-15mg/d.
6, 9
 
Compounding the matter, many women choose foods low in heme iron, from which up to 
10% less iron is absorbed as compared to foods high in heme iron such as meat. 
Additionally, diets high in fiber also limit iron absorption. These qualities are all found in 
the low fat, low animal protein, high fiber diet common amongst endurance athletes.
9
  
 Dietary iron deficiency is compounded with additional losses of iron associated 
with exercise, especially endurance running. Common avenues of iron loss during 
activity include: hemolysis (foot strike hemolysis),
1, 2, 4, 5, 7
 hematuria from bladder wall 
trauma or hypoxic damage to the kidneys,
1, 3-6
 sweat,
1, 3-7
 and GI bleeding from ischemia 
or unknown etiology.
1, 5-8
 These additional losses can bring the iron requirements of a 
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female athlete up to 23mg/d of iron.
6
 Along with losses the inflammation associated with 
activity decreases the ability of the GI tract to absorb iron which can result in low iron 
stores even with sufficient dietary intake.
3-5, 8
 
 The importance of iron deficiency in active women cannot be fully appreciated 
without understanding the functions of iron within the human body. Iron’s primary 
function is to carry and store oxygen throughout the body as a component of hemoglobin 
and myoglobin. However, unless overt anemia is present and oxygen carrying capacity is 
compromised, the lesser known functions of iron are likely more important to athletes. 
Specifically, iron is a component of cytochromes, coenzymes in the Krebs cycle, and part 
of the electron transport chain,
4, 5, 7-9
 which play a major role in the aerobic energy 
pathways and endurance performance.  
 Iron indices used to determine iron deficiency include Hb, Hct, sFer, sFe, TIBC, 
and transferrin saturation. Serum ferritin is the most commonly used index and is often 
the first indicator of inadequate iron intake.
2
 However, the definition of iron deficiency is 
ambiguous and varies in the literature. A sFer value of 20µg/l is the most common cut-off 
point in studies investigating iron deficiency but cut-off values across studies range from 
10-40µg/l.
1, 3, 4, 7-12
  Further, sFer may not be a reliable indicator of iron deficiency as it is 
an acute phase reactant, with levels influenced by factors other than body iron stores such 
as inflammation post exercise, liver disease, cardiovascular disease, high alcohol 
consumption and increasing age.
13
 This issue has led some studies to use a transferrin 
saturation level less than 16% as a definition of iron deficiency.
9
 One author has also 
defined iron deficiency in stages.
7
 Stage I corresponds to a decrease in sFer alone, stage 
II corresponds to decrease in sFer, transferrin saturation, TIBC and sFe and stage III 
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corresponds to true iron deficiency anemia with microcytosis and hypochromia of red 
blood cells. Another author reports a phenomenon specific to athletes that he defined as 
“functional anemia.” The condition is characterized by normal laboratory ranges for iron 
and anemia indices, but the ability to further increase the indices thru supplementation, 
indicates the possibility for inadequate iron stores.
11
  
 Although there exists substantial inconsistency on the definition of iron 
deficiency, most authors agree that it is important to rule out all underlying causes of iron 
deficiency before assuming it is related to activity alone. Even so, many authors still 
recommend iron supplementation in athletes who sFer values are below 35µg/l.
8, 11, 14
 A 
popular way to do so is to ingest elemental iron, where taking 60mg per day with vitamin 
C on an empty stomach has been shown to increase iron stores.
6, 8
 The sFer level at which 
to discontinue supplementation is widely unknown, though one author recommends 
aiming for a sFer of at least 60µg/l.
8
 In any case, frequent testing to evaluate sFer levels 
should be employed during treatment and every six months after treatment has been 
discontinued to monitor maintenance. Overt anemia’s influence on oxygen carrying 
capacity has obvious effects on aerobic exercise but the consequences of low iron levels 
are less understood. Thus the purpose of this review is to evaluate the effects of iron 
repletion on endurance performance in active females who are iron deficient but not 
anemic.  
METHODS 
An extensive literature search of the following databases, MEDLINE-PubMed, 
MEDLINE-Ovid, Web of Science, and CINAHL for the terms “sports,” “dietary 
supplements,” and “iron” was performed. Results were further limited to articles in the 
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English language and studies performed on human subjects. The bibliographies of 
relevant works were searched for additional sources. Further inclusion criteria included 
female athletes greater than 17 years of age, premenopausal status, iron deficient, oral 
iron supplementation and evaluation of exercise performance. Exclusion criteria included 
studies using anemic subjects, parenteral iron supplementation and a treatment period of 
less than four weeks.  All included studies were double blinded and placebo controlled 
without crossover. The quality of the relevant studies was evaluated using the GRADE
15
 
criteria (see Table I). 
RESULTS 
The initial search yielded 135 articles. After eliminating duplicates, non-English 
and non-human subjects’ articles, 96 articles remained for screening. The articles were 
screened for relevant material, leaving 21 articles for review. Two articles met all 
inclusion and exclusion criteria. These articles included female athletes competing in a 
variety of activities including team sports and individual endurance events. Table II 
includes a detailed summary of each study. In brief, each study evaluated hematologic 
indices of iron status and indices of endurance capacity.
16, 17
  
  In the first study reviewed, Klingshirn et al
17
 investigated the effects of iron 
therapy on endurance capacity in female distance runners with low iron levels. They 
included 18 female endurance runners with a sFer less than 20µg/l and a Hb greater than 
120g/l. Women were excluded if they were current smokers, pregnant within the last 
year, had significant blood loss in the past six months, were using medication that had the 
potential to cause bleeding, had an infection within the past month, or a fever in the past 
two weeks. They supplemented nine women with 50mg of elemental iron twice a day for 
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8weeks and the other nine received placebo. The subjects were pair matched based on 
their endurance capacity to help control for variability in physical fitness. Both VO2max 
and a run to exhaustion test were used to evaluate endurance capacity. The time to 
exhaustion test was performed on a treadmill at a pace 2-3% slower than each subject’s 
10K race pace. They were instructed to run until they could no longer maintain that pace. 
Measurements of exercise capacity included VO2, RER, HR, RPE and blood lactate 
levels, while hematologic measures of iron capacity included Hb, Hct, sFe, sFer, TIBC, 
and percent sTrf saturation. Data regarding training and diet history was collected before 
each testing session. The authors found that the treatment group had significantly lower 
TIBC and higher sFer values when compared to the control group after treatment. They 
noted that the sFer was still low and had a large standard deviation (23.44±6.65) after 
treatment. No other changes in hematologic parameters were seen. Furthermore no 
difference in endurance capacity was found between the two groups. Both groups did 
show an increase in time to exhaustion; however the difference did not achieve statistical 
significance. Although not statistically significant the authors did note changes in blood 
lactate levels and RER in the iron treatment group that supported improvement in 
metabolic function. The authors concluded that there was no improvement in endurance 
capacity with iron supplementation.
17
  
 In the second study reviewed, Fogelholm and colleagues
16
 investigated the effects 
of iron repletion on a group of competitive athletes with a sFer less than 25µg/l and a Hb 
greater than 120g/l. No specific exclusion criteria were reported. The study cohort 
included 14 women in the treatment group who received 100mg of ferrous sulfate per day 
for 8 weeks and 17 women in the control who received placebo for the 8 weeks. 
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Hematologic indices of iron status were evaluated before and after treatment and included 
Hb, Hct and sFer. Endurance capacity was determined using an incremental cycle 
ergometer test that evaluated the individuals VO2max, HR and blood lactate levels. The 
authors found that sFer in the treatment group increased significantly from baseline (from 
14µc/l to 26µg/l) as compared to the control group (P=0.001). However, the treatment 
group showed a non-significant increase in Hb and Hct from baseline while the control 
group showed a non-significant decrease, resulting in significantly higher post Hb 
(P=0.001) and Hct (P=0.006) value for the treatment group. Despite this difference, the 
researchers found no difference in the endurance capacity indices. The authors concluded 
that iron repletion did not improve endurance capacity in the group of iron depleted 
females.
16
 
DISCUSSION 
Importance of Iron Repletion in Athletes 
 Iron’s effects on exercise can be considered twofold. First, if iron levels are low 
enough to lead to overt anemia, then oxygen carrying capacity will be diminished and 
therefore VO2max will be reduced. Theoretically, in the absence of anemia no difference in 
oxygen carrying capacity should exist and therefore no difference in VO2max will ensue. 
Second, iron integrates with coenzymes and cofactors necessary for aerobic energy 
production via the Krebs cycle and the electron transport chain. Practically, a decline in 
the efficiency of these pathways may not have an impact on sedentary individuals. 
However, endurance athletes rely heavily on aerobic pathways to function at optimal 
capacity and the lack of coenzymes and cofactors has the potential to severely limit the 
ability of the athlete to perform aerobic work. Hypothetically this concept holds true but 
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studies to date have found little evidence to support improved efficiency of the aerobic 
energy systems when mitigating iron deficiency thru supplementation.  
Outcomes from Current Research 
For the presently reviewed studies
16, 17
 both showed an increase in iron stores (as 
indicated by sFer) following 8 weeks of iron supplementation in iron deficient athletes. 
One study
16
 also showed a decrease in TIBC further indicating an increase in iron stores. 
In both studies,
16, 17
 the effect of increased iron stores on endurance capacity was 
evaluated using a time to exhaustion protocol and neither study showed a significant 
improvement between the treatment and control groups at the end of the treatment period.  
In addition to measuring time to exhaustion serum lactate, HR and percent VO2max 
were used to evaluate endurance capacity. If the aerobic energy systems are working at 
full capacity then the lactate produced by glycolysis will be utilized to produce energy, 
resulting in a lower serum lactate level. If iron supplementation improved the efficiency 
of the aerobic energy system a lower serum lactate level should be observed. For the 
present studies, no significant difference in serum lactate was observed, though one 
study
17
 did show a non-significant decrease in serum lactate in the treatment group. It is 
possible that a longer treatment period may yield greater changes in serum lactate levels. 
Heart rate and the percent VO2max used during the endurance test should indicate 
endurance capacity, with lower values for a given workload being a positive indicator; 
however, neither study showed a between or within group difference following the 
treatment period.  
  
   
13 
 
Problems with Current Research 
 There are multiple hypotheses that may explain the lack of intuitive outcomes and 
consistency within the literature evaluating iron repletion and aerobic activity. One 
hypothesis is that there is inconsistency in the study populations. In the two studies 
reviewed,
16, 17
 all participants were competitive athletes, but not in the same sport. One 
study
17
  used locally competitive endurance runners whereas the other study
16
 also 
included athletes from team sports such as soccer, baseball, basketball, and handball. In 
the latter study the majority of the athletes were not participating in endurance sports. As 
a result the training modality, volume, and intensity vary widely in this study making the 
subjects dissimilar from one another and from the first study’s population of endurance 
runners.
17
 
Another possible hypothesis for inconsistencies is that no standard test for 
endurance capacity has been established. One study used a cycle ergometer
16
 and the 
other used a motorized treadmill. While the choice in exercise modality may seem 
unimportant it may have a significant impact if the athlete is inexperienced with the 
modality or if the modality is different from the activities normally performed by the 
athlete. Further, both studies used time to exhaustion as a measure of endurance capacity 
and such a protocol may not reliably measure endurance capacity as many individuals 
become mentally fatigued before physically fatigued and therefore stop the test 
prematurely.  
Future Research Goals  
Further research is needed to truly evaluate the effect of iron supplementation on 
performance in female athletes. Future studies should employ a larger study population to 
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gain enough statistical power for significant results to have clinically applicable meaning. 
Further, the test of endurance capacity should be consistent with an individuals’ preferred 
activity and less influenced by mental fatigue.  
One study
18
 not reviewed because it was performed on non-athletes, used a study 
methodology more likely to show how iron supplementation would affect athletes. The 
study used a double blind placebo controlled protocol and took 42 women who were iron 
deficient but not anemic and supplemented 22 with 20mg of elemental iron per day for 
two weeks. After two weeks, the women continued their supplementation and began a 
cycle training program designed by the researchers. Endurance capacity was measured 
using a 15km cycle time trial. Despite a lower dose of iron supplementation and a shorter 
treatment period, these authors showed an increase in sFer and a decrease in 15km ride 
time in the treatment group. They also noted a decrease in serum lactate and a decrease in 
the percent VO2max used by the treatment group during the time trial.
18
.  
The overview of the above study is to show that sFer levels may have a larger 
impact when evaluated in reference to a controlled training program. Investigating the 
effect of iron supplementation on training volume and intensity during a controlled 
training program in athletes will provide valuable information regarding the utility of 
treating non anemic iron deficient athletes.  
CONCLUSION 
 Although iron deficiency is a common problem in female athletes and active 
women, current studies do not show that there is a performance benefit with iron 
supplementation in women who are not anemic. However, this question is far from 
answered. Studies employing a larger and more homogenous group of athletes 
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performing a prescribed training program for a period longer than eight weeks are 
necessary to fully understand the impact of iron supplementation on athletes.  
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Table I. Characteristics of Reviewed Studies 
 
 
  
Study Year
Llimitations of 
Methodology
Indirectness Imprecision Inconsistency Publication Bias Likely Quality
Klingshirn et al 
17 1992  serious
a not serious serious
b not serious no bias likely low
Fogelholm et al
16 1992 very serious
a,c not serious serious
b not serious no bias likely very low
a. short duration of trial
b. small sample size
c. lack of exclusion criteria failed to fully account for possible confounders
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Table II. Summary of Findings 
 
 
 
Descriptors Age (years) Supplement Length
iron no difference
TIBC significant ↓
Transferrin saturation no difference
Ferritin significant ↑
Hemoglobin no difference
Hematocrit no difference
VO2max test VO2max no difference
time to exhaustion no difference
blood lactate non significant ↓
RER non significant ↓
ferritin
significant ↑ between & 
within groups
Hemoglobin
significant difference 
between group
Hematocrit
signficant difference 
between group
VO2max test VO2max no difference
time to exhaustion no difference
blood lactate no difference
HR no difference
Inclusion 
Criteria
# Treatment Conclusion# Placebo Outcome Measure Finding
Intervention
Testing
22-39
female endurance 
runners
1992
Study Year
Subjects
100mg elemental 
iron
9
hematologic tests
9
Hb>120
sFer < 20
Klingshirn et al 1992
17
iron repletion 
does not improve 
endurance 
capacity
Fogelholm et al 1992
16
hematologic tests
endurance 
capacity test
1992 female athletes 17-31
Hb >120g/L
sFer <25mcg/L
14 17
100mg ferrous 
sulfate
8 weeks
iron repletion 
does not improve 
endurance 
capacity
endurance 
capacity test
8 weeks
